This bill allows pharmacists to prescribe medications that help people quit smoking, provided they have completed specific state-approved education on tobacco cessation therapies. It directly affects pharmacists and their employers by establishing new prescribing authority within their professional scope. The legislation requires pharmacists to complete education approved by the state board of pharmacy before they can use this new prescribing power. This change aims to expand access to smoking cessation treatments through pharmacies.
Includes routine, scheduled or recommended immunizations to individuals between the ages of three (3) and eighteen (18) years, under the consent and reporting provisions required for pharmacy administered immunizations.
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
This bill prohibits pharmacy benefits managers from engaging in specific deceptive trade practices, including spread pricing, effective rate pricing, and patient steering. It directly affects pharmacy benefits managers, pharmacies, pharmacists, and patients enrolled in health plans administered by these managers within Rhode Island. The legislation defines prohibited actions such as charging higher prices than reimbursed amounts, steering patients toward affiliated pharmacies, penalizing enrollees for pharmacy choices, and misusing patient prescription data for business gain. Violations are classified as unfair and deceptive trade practices, allowing the attorney general to pursue legal remedies for each individual consumer transaction where a prohibited act occurs.
This bill strengthens oversight of pharmacy benefits managers in Rhode Island by requiring them to register with the state and submit detailed annual reports about their financial relationships with insurers. It prohibits these managers from forcing pharmacies to substitute generic drugs without prescriber approval and bans them from stopping pharmacists from sharing pricing information with patients. The legislation also prevents pharmacy benefits managers from charging copayments that exceed what pharmacies are paid and mandates a clear appeals process for disputes over drug pricing. These changes directly affect pharmacy benefits managers, insurers, pharmacies, and patients who use prescription drug coverage in the state.
Requires pharmacy benefit managers to apply for certificate of authority from the office of health insurance commissioner to operate such a business in this state and empowers the commissioner to oversee pharmacy benefit managers and penalize violations.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.
HB 7536 requires health insurance companies in this state to cover specific pharmacist services that would otherwise be covered if provided by physicians, nurse practitioners, or physician assistants. It mandates coverage for services like medication management, immunizations, patient evaluations, and lab test ordering without requiring physician supervision or referrals. Health plans must include pharmacists in their medical provider networks (not just pharmacy drug networks) and cover these services both within and outside their networks when local providers aren't available. The law takes effect January 1, 2027, and expires January 1, 2031, unless extended by the legislature.
HB 7934 amends pharmacy laws to require parental consent for all immunizations given by pharmacists to individuals between the ages of three and eighteen. The bill also mandates that pharmacists electronically report these vaccinations to the Department of Health within seven days and notify the patient's primary care provider within fourteen days. Additionally, pharmacists must make a good-faith effort to identify a patient's primary care provider to facilitate this notification. This legislation directly affects pharmacies, pharmacists, patients, and their parents or guardians.
